Currently, treatment options for patients with recurrence of HL post ASCT include: further salvage chemotherapy, reduced intensity conditioning allogeneic stem cell transplant (alloSCT ...

Contrary to autologous ‘rescue’ stem cell transplantation, the latter approaches avoid giving back cells with possible tumor contamination. We collected data on eight patients who received aut ...

Five other published randomized studies have compared conventional chemotherapy with autologous stem-cell transplantation. 19–23 Overall, transplantation improved the response rate (60 to 80% vs.

As compared with a single autologous stem-cell transplantation after high-dose chemotherapy, double transplantation improves overall survival among patients with myeloma, especially those who do ...

Autologous stem cell transplant for patients with diffuse systemic sclerosis (SSc), without selecting for a particular hematopoietic cell type, performed about as well in a new single-arm trial as ...

Hematopoietic stem cell transplantation ... from around $140,000 for an autologous HSCT to nearly $290,000 for an allogeneic HSCT with a myeloablative pre-transplant treatment.

Autologous stem cell transplantation (ASCT) is a popular treatment option for eligible individuals with multiple myeloma. It can allow people with multiple myeloma to grow healthy blood cells again.

Compared to conventional chemotherapy, autologous stem cell transplantation can extend "event-free survival" for breast cancer patients. Clinical trials provide proof of this for breast cancer ...

Survival in newly diagnosed multiple myeloma improved significantly in patients who underwent early autologous stem cell transplantation (ASCT), according to pooled data from two randomized trials.

If the stem cells come from the person it is called an autologous transplant. If they come from or a donor it is called an allogeneic transplant. A stem cell transplant (SCT) may cause multiple ...